RWD plays a crucial role in cancer research for several reasons:
Generalizability: Data from clinical trials often come from highly controlled environments and may not represent the broader patient population. RWD helps fill this gap by providing insights from diverse and real-world settings. Safety and Efficacy: Post-market surveillance of cancer treatments can identify rare side effects and long-term outcomes that clinical trials may miss. Cost-Effectiveness: RWD can be used to evaluate the economic impact of cancer treatments, helping healthcare providers and policymakers make informed decisions. Patient-Centered Care: Understanding real-world patient experiences and outcomes can inform more personalized and effective care plans.
